15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $304M | $18M | 0.0% | 6.7% | $60M | — | $36M |
| 2024 | $292M | $20M | 0.0% | 7.3% | $56M | — | $59M |
| 2023 | $279M | $15M | 0.0% | 5.7% | $62M | — | $40M |
| 2022 | $267M | $12M | 0.0% | 4.7% | $49M | — | $46M |
| 2021 | $257M | $6M | 0.0% | 3.1% | $39M | — | $47M |
| 2020 | $245M | $14M | 0.0% | 6.5% | $34M | — | $37M |
| 2019 | $254M | $16M | 0.0% | 5.8% | $44M | — | $132M |
| 2018 | $232M | $32M | 0.0% | 6.7% | $36M | — | $134M |
| 2017 | $215M | $10M | 0.0% | 4.4% | $41M | — | $85M |
| 2016 | $192M | $4M | 0.0% | 3.7% | $19M | — | $50M |
| 2015 | — | $9M | — | — | — | — | $82M |
| 2014 | — | $10M | — | — | — | — | $82M |
| 2013 | — | $8M | — | — | $22M | — | $60M |
| 2012 | — | $8M | — | — | $18M | — | $41M |
| 2011 | — | $7M | — | — | $16M | — | $77M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $81M | $6M | 0.0% | 9.3% | $26M | — | $49M |
| Dec '25 | $80M | $3M | 0.0% | 3.0% | $13M | — | $36M |
| Sep '25 | $76M | $6M | 0.0% | 9.9% | $18M | — | $54M |
| Jun '25 | $74M | $5M | 0.0% | 7.9% | $3M | — | $52M |
| Mar '25 | $73M | $4M | 0.0% | 6.0% | $26M | — | $77M |
| Dec '24 | $74M | $5M | 0.0% | 6.3% | $11M | — | $59M |
| Sep '24 | $73M | $6M | 0.0% | 8.9% | $19M | — | $57M |
| Jun '24 | $72M | $4M | 0.0% | 6.2% | $6M | — | $46M |
| Mar '24 | $73M | $5M | 0.0% | 7.8% | $20M | — | $52M |
| Dec '23 | $71M | $5M | 0.0% | 6.0% | $13M | — | $40M |
| Sep '23 | $70M | $4M | 0.0% | 6.9% | $24M | — | $44M |
| Jun '23 | $69M | $4M | 0.0% | 5.8% | $4M | — | $26M |
| Mar '23 | $69M | $3M | 0.0% | 4.2% | $20M | — | $49M |
| Dec '22 | $69M | $2M | 0.0% | 4.5% | $8M | — | $46M |
| Sep '22 | $67M | $4M | 0.0% | 3.5% | $15M | — | $48M |
| Jun '22 | $66M | $3M | 0.0% | 4.5% | $7M | — | $37M |
| Mar '22 | $65M | $3M | 0.0% | 6.2% | $20M | — | $43M |
| Dec '21 | $64M | -$387000 | 0.0% | -0.7% | $5M | — | $47M |
| Sep '21 | $64M | $2M | 0.0% | 2.8% | $12M | — | $55M |
| Jun '21 | $65M | $2M | 0.0% | 5.3% | $5M | — | $50M |
How the market has priced HSTM against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Healthstream Inc's revenue has grown 4.4% per year, and net income grown 5.4% per year. These are computed facts, not advice.
As of FY2025, Healthstream Inc reported — of total debt against $36M of cash.
In FY2025, gross margin was —, operating margin 6.7%, and net margin 6.0%.
As of Jun '26, Healthstream Inc traded at a price-to-earnings ratio of about 40.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.